Skip to main content

Animations

MJFF Publications

4741 - 4750 of 6458 Results
Title
Year
  • Year
  • 2012
  • 2024
  • 2026
  • 2020
  • 2025
  • 2015
  • 2024
  • 2024
  • 2026
  • 2025
  • Summary Details
    OPEN
    Title: GSK2578215A; A potent and highly selective 2-arylmethyloxy-5-substitutent-N-arylbenzamide LRRK2 kinase inhibitor
    Journal Name: Bioorganic & Medicinal Chemistry Letters
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.bmcl.2012.06.104
    Citation Count: 151
  • Summary Details
    OPEN
    Title: Randomized controlled trial of intermittent hypoxia in Parkinson’s disease: study rationale and protocol
    Journal Name: BMC Neurology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s12883-024-03702-3
    Citation Count: 7
  • Summary Details
    OPEN
    Title: A high-content imaging workflow to screen for molecules that reduce cellular uptake of α-synuclein preformed fibrils
    Journal Name: Methods
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.ymeth.2026.05.001
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Screening non-MAPT genes of the Chr17q21 H1 haplotype in Parkinson's disease
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: other-oa
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.07.022
    Citation Count: 17
  • Summary Details
    OPEN
    Title: Long-read sequencing identifies FGF14 repeat expansions in Parkinson’s disease
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/brain/awaf456
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Design, Synthesis, and Characterization of 3-(Benzylidene)indolin-2-one Derivatives as Ligands for α-Synuclein Fibrils
    Journal Name: Journal of Medicinal Chemistry
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1021/acs.jmedchem.5b00571
    Citation Count: 110
  • Summary Details
    OPEN
    Title: Disruption of the LRRK2‐FADD Interface Using Constrained Peptides
    Journal Name: Peptide Science
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/pep2.24374
    Citation Count: 3
  • Summary Details
    OPEN
    Title: An interpretable machine learning‐based cerebrospinal fluid proteomics clock for predicting age reveals novel insights into brain aging
    Journal Name: Aging Cell
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1111/acel.14230
    Citation Count: 12
  • Summary Details
    OPEN
    Title: Variants in the proteasome regulator PSMF1 cause a phenotypic spectrum from parkinsonism to perinatal lethality
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/s41467-026-71351-w
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Assessment of myocardial sympathetic innervation with [123I]mIBG myocardial scintigraphy: A comparative study between an Anger and a ring-configured cadmium-zinc-telluride gamma camera
    Journal Name: Journal of Nuclear Cardiology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.nuclcard.2025.102574
    Citation Count: 0
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.